Pharmacoeconomic analyses make way into oncology.
Amber
D
D
D000970:Antineoplastic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents